Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




CT Angiography Shows Risk of Cerebral Aneurysm Rupture Increases by Growth

By MedImaging International staff writers
Posted on 31 Jul 2013
Cerebral aneurysms of all sizes, even small ones below 7 mm, are 12 times more likely to rupture if they are growing in size, according to new research.

The new findings were published online July 2, 2013, in the journal Radiology. A cerebral aneurysm is a balloon-like bulge in a weakened blood vessel in the brain. If an aneurysm ruptures, blood is leaked into or around the brain, which can cause brain damage or death.

According to the Brain Aneurysm Foundation (Hannover, MA, USA), an estimated six million people in the United States have an unruptured brain aneurysm (1 in 50 people). Ruptured brain aneurysms occur in approximately 30,000 Americans annually and are fatal in about 40% of cases. Of those who survive, approximately two-thirds suffer some permanent neurologic deficit.

“Given what a devastating event a ruptured brain aneurysm is, we are very motivated to identify the real risk factors for rupture,” said the study’s lead author, J. Pablo Villablanca, MD, chief of diagnostic neuroradiology at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA; USA).

In Dr. Villablanca’s study, 258 asymptomatic cerebral aneurysms identified either incidentally or during a baseline study of 165 patients (132 women, 33 men) were monitored over time (mean of 2.24 years) with computed tomography angiography (CTA), a noninvasive imaging study of the brain’s blood vessels. Patients were scanned with CTA at intervals of six or 12 months.

Over the study period, the researchers observed growth in 46 or almost 18% of all the intracranial aneurysms in a total of 38 patients. Three of the 39 growing saccular aneurysms ruptured, and of those, all were less than seven millimeters in size at study entry. “Our study shows that the size of the aneurysm is not as important as was once thought,” Dr. Villablanca said. “Any aneurysm is potentially capable of growth and thus requires follow-up imaging.”

Current guidelines based on research conducted by the International Study of Unruptured Intracranial Aneurysms and other studies suggest that known aneurysms less than 7 mm in size have a low risk of rupture and do not need to be monitored with imaging. Compared to the aneurysms that stayed the same size, the 46 growing aneurysms in the study were associated with a 12-fold higher risk of rupture. The researchers calculated the risk of rupture for growing aneurysms at 2.4% per patient-year, versus 0.2% for aneurysms without growth.

“Our data support the need to perform longitudinal follow-up imaging to monitor for possible growth in all incidental unruptured aneurysms, including small lesions,” Dr. Villablanca said.

The researchers also discovered that tobacco smoking and the initial size of the aneurysm were independent predictors of aneurysm growth. Together, these risk factors were associated with 78.4% of all aneurysm growth in the study. “The positive association between aneurysm growth, aneurysm size, and cigarette smoking suggests that the combination of these factors are associated with an increased risk of rupture and may influence the need for therapeutic intervention,” Dr. Villablanca said.

Observation was the treatment of choice for 194 of 212 (91%) stable aneurysms. When aneurysm growth was discovered by CTA imaging, 50% of the growing aneurysms were treated, while the remaining 50% continued to be observed.

Related Links:

David Geffen School of Medicine at the University of California, Los Angeles



Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Digital Radiographic System
OMNERA 300M
Digital X-Ray Detector Panel
Acuity G4
Mammography System (Analog)
MAM VENUS

Channels

Nuclear Medicine

view channel
Image: This artistic representation illustrates how the drug candidate NECT-224 works in the human body (Photo courtesy of HZDR/A. Gruetzner)

Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies

Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.